Your basket is currently empty!
Mastering Immunity 2025 – Singapore
Mastering Immunity 2025 – Singapore
Asia’s premier scientific event on emerging, tropical, and pandemic infectious diseases
Monday 1 September – Tuesday 2 September 2025, 9am-6pm, In-person only
National University of Singapore, Shaw Foundation Alumni House, Auditorium level 2

Providing scientific thought leadership in areas such as:
| Who should attend?
|
This in-person only symposium, brings together world leaders in infectious disease research to discuss the latest advances in our understanding of emerging and tropical diseases as well as pandemic preparedness. Given the relevance of the Asia pacific region for these topics, ProImmune’s is organizing this unique event in its Mastering Immunity series of events at the National University of Singapore (NUS) Campus.
With a focus on scientific research we aim to communicate and discuss:
|
Secure Your Place – Register Today
Featured Speakers (Additional speakers to be announced)
![]() Public TCR usage of dominant SARS-CoV-2 spike-specific CD4 T cells is associated with mild disease and increased cytotoxicity four-years post COVID-19 Co-Director in CAMS Oxford Institute University of Oxford United Kingdom | ![]() Director General of National Institute of Infectious Diseases NIH Korea, KDCA South Korea | ![]() Director General and President of Chinese Center for Disease Control and Prevention Chinese CDC China |
|
![]() Director in Key Laboratory of Pathogenic Microbiology and Immunology Institute of Microbiology, Chinese Academy of Sciences China | ![]() Panel Discussion Moderator Professor in Program of Emerging Infectious Diseases Duke-NUS Singapore | ![]() Vaccine science and adjuvant design by nucleic acids Director in International Vaccine Design Center The University of Tokyo Japan | ![]() CD8+ T cell differentiation and its clinical significance after COVID-19 mRNA vaccination Professor in Graduate School of Medical Science and Engineering KAIST South Korea |
![]() A cell-based method to identify target antigens and assess antibody responses President's Chair in Infectious Diseases Nanyang Technological University Singapore | ![]() mRNA Vaccine and Pandemic Preparedness Director in Chula Vaccine Research Center Chulalongkorn University Thailand | ![]() Associate Professor in CAMS Oxford Institute University of Oxford United Kingdom |
|
![]() Where to from here for vaccine adjuvants? Professor of Immunology and Infectious Disease Australian Respiratory and Sleep Medicine Institute Australia | ![]() Next Generation Zika Virus Vaccine Assistant Dean in Yong Loo Lin School of Medicine NUS Singapore | ![]() Methylene Blue Treatment Unveils Potential Blood Biomarkers in Fatal Cerebral Malaria: Insights from the Coatneyi-Infected Macaque Model Associate Professor in Department of Microbiology and Immunology NUS Singapore | ![]() A versatile and powerful dendritic cell-targeting platform to deliver vaccine antigen candidates against infectious diseases Programme Director at Infectious Diseases Translational Research Programme NUS Singapore |
![]() Professor in Immunology and Molecular Medicine University of Sri Jayawardenepura Sri Lanka | ![]() Multiple Roles of Antigen-Specific High-Avidity CD4+ T Cells in Humans Professor in Department of Immunology Kyoto University Japan |
||
![]() Immune Divergence Between Vaccine-Associated and Conventional Myocarditis Associate Professor in Graduate School of Medical Science and Engineering KAIST South Korea | ![]() Preclinical study of TB vaccine development using viral vector and mRNA delivering platforms Associate Professor of Immunology Prince of Songkla University Thailand | ![]() Clonotypic tracing of human T cells during infection Professor in Molecular Immunology, Research Institute for Microbial Diseases The University of Osaka Japan | ![]() Assistant Professor in Program of Emerging Infectious Diseases Duke-NUS Singapore |
![]() Rethinking Immunity in Dengue: A T Cell Twist Chief in Vaccine Immunology Lab National Institute of Immunology India | ![]() Adding a twist to lateral flow immunoassay: replacing antibodies with non-animal derived protein binders Senior Researcher & Theme Leader University of Oxford United Kingdom | ![]() Research Assistant Professor in Infectious Diseases Translational Research Programme NUS Singapore |
|
![]() Highly activated intrahepatic HBV-specific resident-memory T and B cells correlated with acute-on-chronic liver failure Assistant Professor in Institute of Biomedical Sciences Academia Sinica Taiwan, China |
What to Expect at This Meeting:
|
|
Call for Abstracts & Poster Presentations
Key Details:
| Why Present?
|
Review Process: All submissions will be evaluated by our Scientific Review Committee. Accepted presenters will be notified with ample time to prepare their:
|
How to get there?

Highlights from Previous Mastering Immunity Meetings are available online free of charge



About ProImmune
In its 25 year history ProImmune has supported successful infectious disease research with its unique range of products and technologies ranging from MHC multimers through its unique in vitro and cell based immunology assay services as well as its next generation Ankyron binding and detection technology that is rapidly covering new targets in infectious disease biology across a broad range of areas. Our published work includes groups from USAMRIID, UK DSTL, The Oxford Vaccine Group, NUS and many others.
ProImmune’s Mastering Immunity series of symposia has successfully brought together thousands of scientists from various organizations worldwide, uniting efforts to tackle practical challenges and share cutting-edge knowledge about measuring both desired and undesired immune responses.
Understanding immunology is crucial across multiple domains, including research on emerging infectious diseases, vaccine and diagnostic development, and the shaping of international and national pandemic preparedness policies.
Equipping ourselves with the right tools and knowledge is essential for enhancing our operational efficiency in combating infectious diseases—encompassing prevention, detection, preparedness, response, and management. In this symposium, our expert speakers will showcase the latest advancements in understanding emerging infectious diseases and strategies for pandemic preparedness.
By participating, you will have the unique opportunity to learn from renowned global experts as they share their latest findings and perspectives. Engage in thought-provoking discussions, gain firsthand knowledge of the most recent developments, and contribute to the conversation during our moderated panel sessions. Don’t miss this chance to be part of a transformative event that bridges science, policy, and practice in the fight against infectious diseases.
Registration Fees*
Early Bird Registration** (Till 30th June) | USD784 / EUR728 / GBP608 |
Standard Registration | USD980 / EUR910 / GBP760 |
*Other countries are invoiced in GBP, with the exception of the USA and Canada, which are invoiced in USD. EUR are applicable for the following countries highlighted in the table here |
|
**Free access to this event to one hundred undergraduate and graduate students in biological sciences by submitting a justification in the application form. |
For all Conference Enquiries:
Email: enquiries@proimmune.com